Paradigm Biopharmaceuticals | PAR - Operating Profit

Stock Price
0.26
Daily Change
0.01 2.00%
Monthly
-12.07%
Yearly
-38.55%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD-8.5M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025